Abaxis releases new Piccolo reagent disc panel Abaxis, Inc. As a total result of this fresh panel configuration, U.S Read more . Healthcare experts is now able to conduct on-site chemistry evaluation in under 12 moments for general irritation and infection in conjunction with comprehensive liver and kidney function diagnostics. The brand new BioChemistry Panel Plus contains the C-Reactive Proteins assay that received 510 clearance in late January 2010. This configuration has a broad spectrum of inner organ diagnostics including liver, kidney, pancreas and metabolic functions. Related StoriesHealthcare technology public event of the entire year opens entriesScientists discover little molecule that may block development of BRCA-deficient tumor cellsMelatonin and the circadian rhythm: an interview with Professor Kennaway, University of AdelaideThe BioChemistry Panel Plus may very well be useful for methods that want in the detection, monitoring and treatment of diseases with inflammation or contamination disorders.
Aastrom Biosciences responds to article regarding contaminated stem cell lines Aastrom Biosciences responded today to the publication in the Sunday online edition of Character Medicine of results by California experts that indicate that one lines of human being embryonic stem cells have already been contaminated by using mice feeder cells. The Company has received many inquiries regarding these findings and their effect on Aastrom Biosciences. Aastrom does not make use of embryonic stem cells, nor will it make use of mouse-derived feeder cells to support stem cell growth, both major topics of yesterday’s article. This is a critical reality that differentiates our Tissue Repair Cells from additional stem cell approaches presently in development. Aastrom utilizes proprietary technology in the production of its TRCs, which are a grown-up, patient-derived bone marrow progenitor and stem cell mixture.